Bruce Hammock - Davis CA, US Jiang Zheng - Seattle WA, US Christophe Morisseau - Davis CA, US Kazuhiko Motoba - Kawachinagano, JP Mehran Moghaddam - San Diego CA, US Babak Borhan - East Lansing MI, US David Grant - Storrs CT, US Jessica Greene - Oakland CA, US Marlene Sisemore - Davis CA, US James Sanborn - Sacramento CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/66 A61K 31/17
US Classification:
514114000, 514580000, 514588000
Abstract:
The invention provides compounds that inhibit epoxide hydrolase in therapeutic applications for treating hypertension. A preferred class of compounds for practicing the invention have the structure shown by Formula 1 wherein Z is oxygen or sulfur, W is carbon phosphorous or sulfur, X and Y is each independently nitrogen, oxygen, or sulfur, and X can further be carbon, at least one of R-Ris hydrogen, Ris hydrogen when X is nitrogen but is not present when X is sulfur or oxygen, Ris hydrogen when Y is nitrogen but is not present when Y is sulfur or oxygen, Rand Ris each independently C-Csubstituted or unsubstituted alkyl, cycloalkyl, aryl, acyl, or heterocyclic.
Bruce D. Hammock - Davis CA Mehran F. Moghaddam - Wilmington DE Jeffrey M. Cheek - Sacramento CA Babak Borhan - New York NY James Fergusson - Davis CA David F. Grant - Little Rock AK Jessica F. Greene - Davis CA Kazuhiko Matoba - Osaka, JP Jiang Zheng - Davis CA Marlene F. Sisemore - Davis CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3134 C07D30712
US Classification:
514473
Abstract:
The present invention provides novel biologically active tetrahydrofuran diols of arachidonic acid.
Bruce D. Hammock - Davis CA Mehran F. Moghaddam - Wilmington DE Jeffrey M. Cheek - Sacramento CA Babak Borhan - New York NY James Fergusson - Davis CA David F. Grant - Little Rock AR Jessica F. Greene - Davis CA Kazuhiko Matoba - Osaka, JP Jiang Zheng - Davis CA Marlene F. Sisemore - Davis CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12Q 134
US Classification:
435 18
Abstract:
The present invention provides methods of treating inflammatory diseases mediated by poly-unsaturated lipid metabolites by inhibiting epoxide hydrolase, methods for assaying or screening the epoxide hydrolase inhibitors for inhibitory specificity and for toxicity, and novel biologically active tetrahydrofuran diols of arachidonic acid, including antibodies thereto.